856245-74-4 Usage
Chemical structure
The compound contains a 1,2,4-triazole ring system fused to a pyridazine ring, with chlorophenyl and trifluoromethylphenyl substituents.
Novelty
It is a novel pyridazine derivative.
Potential therapeutic applications
The compound has potential therapeutic applications due to its unique structure.
Biological activities
The compound's unique structure suggests potential biological activities, which could make it a drug candidate for further investigation and development.
Pharmacological profile
The precise pharmacological profile of the compound is yet to be fully elucidated.
Toxicological profile
The precise toxicological profile of the compound is yet to be fully elucidated.
Further research needed
Further research is needed to determine the compound's potential applications in various fields such as pharmaceuticals and agrochemicals.
Potential fields of application
The compound could potentially be used in pharmaceuticals and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 856245-74-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,6,2,4 and 5 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 856245-74:
(8*8)+(7*5)+(6*6)+(5*2)+(4*4)+(3*5)+(2*7)+(1*4)=194
194 % 10 = 4
So 856245-74-4 is a valid CAS Registry Number.
856245-74-4Relevant academic research and scientific papers
Azabicyclic heterocycles as cannabinoid receptor modulators
-
Page/Page column 20, (2008/06/13)
The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula I: including all prodrugs, pharmaceutically acceptable salts and stereoisomers, R1, R2, R3, R6, R7, m and n are described herein.
